Pharmacology and immunology of botulinum toxin type A
- 1 November 2003
- journal article
- review article
- Published by Elsevier in Clinics in Dermatology
- Vol. 21 (6), 476-480
- https://doi.org/10.1016/j.clindermatol.2003.11.006
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Evaluation of the Therapeutic Usefulness of Botulinum Neurotoxin B, C1, E, and F Compared with the Long Lasting Type AJournal of Biological Chemistry, 2003
- Dysport produces intrinsically more swallowing problems than Botox: unexpected results from a conversion factor study in cervical dystoniaJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosingJournal of Cosmetic and Laser Therapy, 2002
- Botulinum B treatment of the glabellar and frontalis regions: a dose response analysisJournal of Cosmetic and Laser Therapy, 2002
- Botulinum toxin type A (BOTOX) for treatment of migraine headaches: An open‐label studyOtolaryngology -- Head and Neck Surgery, 2000
- Long-term botulinum toxin treatment of cervical dystonia – EMG changes in injected and noninjected musclesClinical Neurophysiology, 1999
- Physiological effects produced by botulinum toxin: Changes in reciprocal inhibition between forearm musclesBrain, 1995
- Histologic assessment of dose‐related diffusion and muscle fiber response after therapeutic botulinum a toxin injectionsMovement Disorders, 1994
- Botulinum a Toxin Effects on Rat Jaw Muscle SpindlesActa Oto-Laryngologica, 1993
- Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevinNature, 1992